Remedent Balance Sheet

Financials in millions EUR. Fiscal year is April - March.

Millions EUR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019
Cash & Equivalents	0.03	0	0	0.06	0.06
Cash & Short-Term Investments	0.03	0	0	0.06	0.06
Cash Growth	999.25%	62.62%	-97.56%	7.25%	-21.36%
Accounts Receivable	2.35	2.31	2.04	1.89	0.21
Other Receivables	0.06	0.22	0	0.06	-
Receivables	2.41	2.53	2.05	1.95	0.21
Inventory	0.08	0.09	0.09	0.08	0.1
Prepaid Expenses	-	-	-	-	0.22
Other Current Assets	-0	0	-	-0	-
Total Current Assets	2.52	2.62	2.13	2.09	0.58
Property, Plant & Equipment	0.01	0.02	0	0	0.11
Long-Term Investments	1.89	1.97	2.05	2.15	6.34
Other Intangible Assets	0.02	0.03	0.05	-	-
Long-Term Deferred Charges	-	-	-	0.05	-
Total Assets	4.45	4.64	4.24	4.29	7.04
Accounts Payable	1.29	1.17	0.91	1.03	1.71
Accrued Expenses	0.17	0.19	0.16	0.12	0.4
Current Income Taxes Payable	0.03	0.03	0.06	0.04	0
Current Unearned Revenue	-	-	-	-	0.06
Other Current Liabilities	0.04	0.04	0.02	0.03	0.01
Total Current Liabilities	1.54	1.42	1.16	1.22	2.17
Other Long-Term Liabilities	-	0.01	0.01	0.01	-
Total Liabilities	1.54	1.44	1.17	1.22	2.17
Common Stock	2.21	2.21	2.21	2.21	0.02
Additional Paid-In Capital	-	-	-	-	22.19
Retained Earnings	0.69	1	0.86	0.86	-15.79
Treasury Stock	-	-	-	-	-0.74
Comprehensive Income & Other	-	-	-	-	-0.88
Total Common Equity	2.9	3.21	3.07	3.07	4.8
Minority Interest	-	-	-	-	0.06
Shareholders' Equity	2.9	3.21	3.07	3.07	4.87
Total Liabilities & Equity	4.45	4.64	4.24	4.29	7.04
Net Cash (Debt)	0.03	0	0	0.06	0.06
Net Cash Growth	999.25%	62.62%	-97.56%	7.25%	77.73%
Net Cash Per Share	-	-	-	-	0.00
Filing Date Shares Outstanding	-	-	-	19.27	19.27
Total Common Shares Outstanding	-	-	-	19.27	19.27
Working Capital	0.98	1.2	0.97	0.87	-1.58
Book Value Per Share	-	-	-	0.16	0.25
Tangible Book Value	2.88	3.17	3.03	3.07	4.8
Tangible Book Value Per Share	-	-	-	0.16	0.25
Machinery	-	-	-	0.7	2.35